These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1004 related items for PubMed ID: 23026657
1. Antiphospholipid antibodies: evaluation of the thrombotic risk. Devreese KM. Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657 [Abstract] [Full Text] [Related]
2. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays. Chayoua W, Kelchtermans H, Moore GW, Musiał J, Wahl D, de Laat B, Devreese KMJ. J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628 [Abstract] [Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
5. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India. Ahluwalia J, Sreedharanunni S, Kumar N, Masih J, Bose SK, Varma N, Varma S, Singh S. Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011 [Abstract] [Full Text] [Related]
6. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome. Iwaniec T, Kaczor MP, Celińska-Löwenhoff M, Polański S, Musiał J. Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116 [Abstract] [Full Text] [Related]
7. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome]. Fujieda Y, Shida H, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T. Nihon Rinsho Meneki Gakkai Kaishi; 2014 May; 37(5):430-6. PubMed ID: 25744643 [Abstract] [Full Text] [Related]
8. Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants. Favaloro EJ. Int J Lab Hematol; 2013 Jun; 35(3):269-74. PubMed ID: 23590654 [Abstract] [Full Text] [Related]
9. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome? Chayoua W, Yin DM, Kelchtermans H, Moore GW, Gris JC, Musiał J, Zuily S, Ten Cate H, de Laat B, Devreese KMJ. Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448 [Abstract] [Full Text] [Related]
10. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I. Sanfelippo MJ, Joshi A, Schwartz S, Meister JA, Goldberg JW. Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738 [Abstract] [Full Text] [Related]
11. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Persijn L, Decavele AS, Schouwers S, Devreese K. Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896 [Abstract] [Full Text] [Related]
12. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome. De Craemer AS, Musial J, Devreese KM. J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634 [Abstract] [Full Text] [Related]
13. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related]
14. [Laboratory examinations in antiphospholipid syndrome]. Ieko M, Naito S, Yoshida M. Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762 [Abstract] [Full Text] [Related]
15. Antibody profiles for the diagnosis of antiphospholipid syndrome. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401 [Abstract] [Full Text] [Related]
16. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, Ahn YS. Thromb Res; 2007 Jun; 121(3):319-25. PubMed ID: 17582471 [Abstract] [Full Text] [Related]
17. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E. Lupus; 2007 Jun; 16(1):39-45. PubMed ID: 17283584 [Abstract] [Full Text] [Related]
18. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome. Galli M. Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065 [Abstract] [Full Text] [Related]
19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [Abstract] [Full Text] [Related]
20. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study. Mustonen P, Lehtonen KV, Javela K, Puurunen M. Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]